Adicet Bio, Inc. Common Stock (ACET) is a publicly traded Healthcare sector company. As of September 21, 2026, ACET trades at $8.90 with a market cap of $85.94M and a P/E ratio of -0.54. ACET moved -3.49% today. Year to date, ACET is +9.03%; over the trailing twelve months it is -29.20%. Its 52-week range spans $6.01 to $17.44. Analyst consensus is strong buy with an average price target of $22.50. Rallies surfaces ACET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ACET combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $8.90 |
| Market Cap | $85.94M |
| P/E Ratio | -0.54 |
| EPS | $-16.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.44 |
| 52-Week Low | $6.01 |
| Volume | 25.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-116.80M |
| Gross Margin | 0.00% |
4 analysts cover ACET: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.50.